Athens Medical C.S.A.
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and … Read more
Athens Medical C.S.A. (IATR) - Total Liabilities
Latest total liabilities as of June 2025: €416.15 Million EUR
Based on the latest financial reports, Athens Medical C.S.A. (IATR) has total liabilities worth €416.15 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Athens Medical C.S.A. - Total Liabilities Trend (2014–2024)
This chart illustrates how Athens Medical C.S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Athens Medical C.S.A. Competitors by Total Liabilities
The table below lists competitors of Athens Medical C.S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shaver Shop Group Ltd
AU:SSG
|
Australia | AU$71.65 Million |
|
Metal Powder Works Ltd
AU:MPW
|
Australia | AU$2.10 Million |
|
Rico Auto Industries Limited
NSE:RICOAUTO
|
India | ₹12.90 Billion |
|
SAMYOUNG M-Tek Co. Ltd
KQ:054540
|
Korea | ₩66.91 Billion |
|
Samhwa Paint
KO:000390
|
Korea | ₩291.59 Billion |
|
ENB Financial Corp
OTCQX:ENBP
|
USA | $2.09 Billion |
|
Ramco Industries Limited
NSE:RAMCOIND
|
India | ₹4.56 Billion |
|
UNIMECH
NSE:UNIMECH
|
India | ₹1.64 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Athens Medical C.S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.79 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Athens Medical C.S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Athens Medical C.S.A. (2014–2024)
The table below shows the annual total liabilities of Athens Medical C.S.A. from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €387.05 Million | +5.01% |
| 2023-12-31 | €368.57 Million | +17.07% |
| 2022-12-31 | €314.84 Million | -1.83% |
| 2021-12-31 | €320.69 Million | -3.25% |
| 2020-12-31 | €331.48 Million | +14.69% |
| 2019-12-31 | €289.03 Million | +0.41% |
| 2018-12-31 | €287.84 Million | -3.50% |
| 2017-12-31 | €298.28 Million | -3.16% |
| 2016-12-31 | €308.01 Million | -1.09% |
| 2015-12-31 | €311.40 Million | +1.45% |
| 2014-12-31 | €306.93 Million | -- |